Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 28, 2009

Stroke. 2009
Published online before print May 28, 2009, doi: 10.1161/STROKEAHA.109.550699
A more recent version of this article appeared on August 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/8/2869    most recent
STROKEAHA.109.550699v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, T. J.
Right arrow Articles by Nowak-Göttl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, T. J.
Right arrow Articles by Nowak-Göttl, U.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Blood Thinners
Related Collections
Right arrow Heparin
Right arrow Anticoagulants
Right arrow Other Vascular biology

Submitted on February 19, 2009
Accepted on March 12, 2009

Anticoagulation in Childhood-Onset Arterial Ischemic Stroke With Nonmoyamoya Arteriopathy. Findings From the Colorado and German (COAG) Collaboration

Timothy J. Bernard MD*; Neil A. Goldenberg MD, PhD; Mark Tripputi MS; Marilyn J. Manco-Johnson MD; Thomas Niederstadt MD; and Ulrike Nowak-Göttl MD

From the Sections of Child Neurology (T.J.B.) and Hematology/Oncology/BMT (N.A.G., M.J.M.-J.), Department of Pediatrics, the Department of Biostatistics and Informatics (M.T.), and the Hemophilia and Thrombosis Center (T.J.B., N.A.G., M.J.M.-J.), University of Colorado Denver and The Children's Hospital, Denver, Colo; and the Institute of Clinical Radiology/Neuroradiology (T.N.) and the Department of Pediatric Hematology/Oncology, University Children's Hospital (U.N.-G.), University of Münster, Münster, Germany (T.N., U.N.-G.).

* To whom correspondence should be addressed. E-mail: timothy.bernard{at}uchsc.edu.

Background and Purpose—Childhood arterial ischemic stroke treatment guidelines recommend extended anticoagulation in cardioembolism and dissection. We sought to investigate the safety of extended anticoagulation in childhood arterial ischemic stroke with nonmoyamoya arteriopathy, for which the risk of recurrent stroke is high.

Methods—Thirty-seven patients with childhood-onset arterial ischemic stroke with acute arteriopathy (excluding moyamoya) were diagnosed between 1999 and 2007 and treated with anticoagulation for at least 4 weeks. Patients were followed in hospital-based cohort studies at 2 centers and systematically assessed for bleeding episodes and recurrent events.

Results—Over a cumulative anticoagulation duration of 1329 patient-months, there were no major bleeding episodes and 2 clinically relevant bleeding episodes. Cumulative probability of recurrent arterial ischemic stroke at 1 year was 14%.

Conclusions—Anticoagulation can be used safely for secondary arterial ischemic stroke prevention in children with acute nonmoyamoya arteriopathy. Anticoagulation is worthy of evaluation in future randomized, controlled treatment trials in this disease.


Key words: anticoagulation • arteriopathy • childhood stroke